Developmental exposure to TCDD reduces fertility and negatively affects pregnancy outcomes across multiple generations

Reproductive Toxicology

Volumn 31, Issue 3, 2011, Pages 344-350

  Bruner Tran, Kaylon L ^a   Osteen, Kevin G ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Development; Fertility; Inflammation; Mouse parvo virus; Preterm birth; Progesterone receptor; TCDD

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; LIPOPOLYSACCHARIDE; PROGESTERONE RECEPTOR;

ADULT ANIMAL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE TRANSMISSION; ENVIRONMENTAL EXPOSURE; FEMALE; FEMALE FERTILITY; GENITAL SYSTEM FUNCTION; GESTATIONAL AGE; INFLAMMATORY DISEASE; MALE; MOUSE; NONHUMAN; POLYOMA VIRUS; PREGNANCY OUTCOME; PREMATURITY; PRENATAL EXPOSURE; PROTEIN EXPRESSION; RISK FACTOR;

ANIMALS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENTAL POLLUTANTS; EPIGENESIS, GENETIC; FEMALE; FERTILITY; MALE; MATERNAL EXPOSURE; MICE; MICE, INBRED C57BL; PREGNANCY; PREMATURE BIRTH; PRENATAL EXPOSURE DELAYED EFFECTS; TETRACHLORODIBENZODIOXIN; UTERUS;

ANIMALIA; MUS; PARVOVIRUS;

EID: 79953744516     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.reprotox.2010.10.003     Document Type: Article

References (43)

1. Jones P.A., Baylin S.B. The epigenomics of cancer. Cell 2007, 128:683-692.
2. Heindel J.J. Role of exposure to environmental chemicals in the developmental basis of reproductive disease and dysfunction. Semin Reprod Med 2006, 24:168-177.
3. Anway M.D., Skinner M.K. Epigenetic transgenerational actions of endocrine disruptors. Endocrinology 2006, 47:S43-S49.
4. Anway M.D., Skinner M.K. Epigenetic programming of the germ line: effects of endocrine disruptors on the development of transgenerational disease. Reprod Biomed Online 2008, 16:23-25.
5. Skinner M.K. Endocrine disruptors and epigenetic transgenerational disease etiology. Pediatr Res 2007, 61:48R-50R.
6. Hombach-Klonisch S., Pocar P., Kietz S., Klonisch T. Molecular actions of polyhalogenated arylhydrocarbons (PAHs) in female reproduction. Curr Med Chem 2005, 12:599-616.
7. Bruner-Tran K.L., Ding T., Osteen K.G. Dioxin and endometrial progesterone resistance. Semin Reprod Med 2010, 28:59-68.
8. Zook D., Rappe C. Environmental sources, distribution, and fate of polycholorinated dibenzodioxins, dibenzofurans and related organochlorines. Dioxins and health 1994, 79-113. Plenum Press, New York. A. Schecter (Ed.).
9. McNulty W.P. Toxicity and fetotoxicity of TCDD, TCDF and PCB isomers in rhesus macaques (Macaca mulatta). Environ Health Perspect 1985, 60:77-88.
10. Sever L.E., Arbuckle T.E., Sweeney A. Reproductive and developmental effects of occupational pesticide exposure: the epidemiologic evidence. Occup Med 1997, 12:305-325.
11. Birnbaum L.S., Tuomisto J. Non-carcinogenic effects of TCDD in animals. Food Addit Contam 2000, 17:275-288.
12. Le T.N., Johansson A. Impact of chemical warfare with agent orange on women's reproductive lives in Vietnam: a pilot study. Reprod Health Matters 2001, 9:156-164.
13. Birnbaum L.S. The mechanism of dioxin toxicity: relationship to risk assessment. Environ Health Perspect 1994, 102:157-167.
14. Schecter A., Wallace D., Pavuk M., Piskac A., Papke O. Dioxins in commercial United States baby food. J Toxicol Environ Health A 2002, 65:1937-1943.
15. Harrad S., Wang Y., Sandaradura S., Leeds A. Human dietary intake and excretion of dioxin-like compounds. J Environ Monit 2003, 5:224-228.
16. Pompa G., Caloni F., Fracchiolla M.L. Dioxin and PCB contamination of fish and shellfish: assessment of human exposure. Review of the international situation. Vet Res Commun 2003, 27:159-167.
17. Domingo J.L., Bocio A. Levels of PCDD/PCDFs and PCBs in edible marine species and human intake: a literature review. Environ Int 2007, 33:397-405.
18. Dewailly E., Ryan J.J., Laliberte' C., Bruneau S., Weber J.P., Gingras S., et al. Exposure of remote maritime populations to coplanar PCBs. Environ Health Perspect 1994, 102:205-209.
19. Nayyar T., Bruner-Tran K.L., Piestrzeniewicz-Ulanska D., Osteen K.G. Developmental exposure of mice to TCDD elicits a similar uterine phenotype in adult animals as observed in women with endometriosis. Reprod Toxicol 2007, 23:326-336.
20. Virgo B.B., Bellward G.D. Serum progesterone levels in the pregnant and postpartum laboratory mouse. Endocrinology 1974, 95:1486-1490.
21. Lydon J.P., DeMayo F.J., Conneely O.M., O'Malley B.W. Reproductive phenotpes of the progesterone receptor null mutant mouse. J Steroid Biochem Mol Biol 1996, 56:67-77.
22. Brown A.G., Leiter R.S., Strauss J.F. Mechanisms underlying " functional" progesterone withdrawal at parturition. Ann N Y Acad Sci 2004, 1034:36-49.
23. Druckmann R., Druckmann M.A. Progesterone and the immunology of pregnancy. J Steroid Biochem Mol Biol 2005, 97:389-396.
24. Miniero R., De Felip E., Ferri F., di Domenico A. An overview of TCDD half-life in mammals and its correlation to body weight. Chemosphere 2001, 43:839-844.
25. Vogel C.F., Zhao Y., Wong P., Young N.F., Matsumura F. The use of c-src knockout mice for the identification of the main toxic signaling pathway of TCDD to induce wasting syndrome. J Biochem Mol Toxicol 2003, 17:305-315.
26. Lanman J.T., Seidman L. Length of gestation in mice under a 21-hour day. Biol Reprod 1977, 17:224-227.
27. Wang H., Xie H., Dey S.K. Loss of cannabinoid receptor CB1 induces preterm birth. PLoS One 2008, 3(10):e3320.
28. Roizen J.D., Asada M., Tong M., Tai H.H., Muglia L.J. Preterm birth without progesterone withdrawal in 15-hydroxyprostaglandin dehydrogenase hypomorphic mice. Mol Endocrinol 2008, 22:105-112.
29. Gorivodsky M., Torchinsky A., Zemliak I., Savion S., Fein A., Toder V. TGF beta 2 mRNA expression and pregnancy failure in mice. Am J Reprod Immunol 1999, 42:124-133.
30. Clark D.A., Croitoru K. TH1/TH2,3 imbalance due to cytokine-producing NK, gammadelta T and NK-gammadelta T cells in murine pregnancy decidua in success or failure of pregnancy. Am J Reprod Immunol 2001, 45:257-265.
31. Meis P.J. 17 hydroxyprogesterone for the prevention of preterm delivery. Obstet Gynecol 2005, 105:1128-1135.
32. McKisic M.D., Lancki D.W., Otto G., Padrid P., Snook S., Cronin D.C. Identification and propagation of a putative immunosuppressive orphan parvovirus in cloned T cells. J Immunol 1993, 150:419-428.
33. Jacoby R.O., Ball-Goodrich L.J., Besselsen D.G., McKisic M.D., Riley L.K., Smith A.L. Rodent parvovirus infections. Lab Anim Sci 1996, 46:370-380.
34. Elovitz M.A., Wang Z., Chien E.K., Rychlik D.F., Phillippe M. A new model for inflammation-induced preterm birth: the role of platelet-activating factor and Toll-like receptor-4. Am J Pathol 2003, 163:2103-2111.
35. Elovitz M., Wang Z. Medroxyprogesterone acetate, but not progesterone, protects against inflammation-induced parturition and intrauterine fetal demise. Am J Obstet Gynecol 2004, 190:693-701.
36. Bruner-Tran K.L., Osteen K.G. Omega-3 fatty acids prevent inflammation-mediated preterm birth in a mouse model. 57th annual society of gynecologic investigation meeting 2010.
37. Environmental Working Group. Body burden-the pollution in newborns: a benchmark investigation of industrial chemicals, pollutants and pesticides in umbilical cord blood [Internet], available from: [cited 06.07.10]. http://www.ewg.org/reports/bodyburden2/execsumm.php.
38. Heimler I., Rawlins R.G., Owen H., Hutz R.J. Dioxin perturbs, in a dose- and time-dependent fashion, steroid secretion, and induces apoptosis of human luteinized granulosa cells. Endocrinology 1998, 139:4373-4379.
39. Gregoraszczuk E.L., Zabielny E., Ochwat D. Aryl hydrocarbon receptor (AhR)-linked inhibition of luteal cell progesterone secretion in 2,3,7,8-tetrachlorodibenzo-p-dioxin treated cells. J Physiol Pharmacol 2001, 52:303-311.
40. Kakeyama M., Tohyama C. Developmental neurotoxicity of dioxin and its related compounds. Ind Health 2003, 41:215-230.
41. Eskenazi B., Warner M., Marks A.R., Samuels S., Needham L., Brambilla P., et al. Serum dioxin concentrations and time to pregnancy. Epidemiology 2010, 21:224-231.
42. Ball-Goodrich L.J., Johnson E. Molecular characterization of a newly recognized mouse parvovirus. J Virol 1994, 68:6476-6486.
43. McKisic M.D., Paturzo F.X., Smith A.L. Mouse parvovirus infection potentiates rejection of tumor allografts and modulates T cell effector functions. Transplantation 1996, 61:292-299.